| 1 |
Tumour budding is a novel marker in breast cancer: the clinical application and future prospects |
|
|
| Ting Huang, Hui Bao, Yu-hua Meng, Jian-lin Zhu, Xiao-dong Chu, Xiao-li Chu, Jing-hua Pan |
|
| Annals of Medicine. 2022; 54(1): 1303 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Comparative analysis of phenotypic features in the primary tumor, tumour buds and metastatic lymph nodes within Luminal A and Luminal B molecular subtypes of invasive ductal carcinoma of the breast |
|
|
| Shota Kepuladze, Irakli Kokhreidze, George Burkadze |
|
| GEORGIAN SCIENTISTS. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6 |
|
|
| Marwa Mohammed Serag Eldien, Asmaa Gaber Abdou, Gehad Raafat Amein Elghrabawy, Alshimaa Mahmoud Alhanafy, Shereen Fathy Mahmoud |
|
| Journal of Immunoassay and Immunochemistry. 2021; 42(6): 662 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Prognostic Role of Tumor Budding in Breast Cancer Patients Receiving Neo-Adjuvant Therapy |
|
|
| Paul Mozarowski, Bhubendra Rasaiah, Melissa Reed, Alexis Lewis, Natalie Walde, Ioannis A. Voutsadakis |
|
| Journal of Clinical Medicine. 2021; 10(4): 827 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
GATA-3 Expression in all Grades and Different Variants of Primary and Metastatic Urothelial Carcinoma |
|
|
| Meenatai Naik, B. Vishal Rao, Daphne Fonseca, S. Sudha Murthy, Ashwin Giridhar, Rakesh Sharma, KVVN Raju, T. Subramanyeswar Rao, Sundaram Challa |
|
| Indian Journal of Surgical Oncology. 2021; 12(S1): 72 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants |
|
|
| Chanchal Rana, Suresh Babu, Harshita Agarwal, Atin Singhai, Madhu Kumar, Vishwajeet Singh, R. J. Sinha, S. N. Shankhwar |
|
| Indian Journal of Surgical Oncology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Tumor Budding is a reliable predictor for death and metastasis in invasive ductal breast cancer and correlates with other prognostic clinicopathological parameters |
|
|
| Oguzhan Okcu, Çigdem Öztürk, Bayram Sen, Medeni Arpa, Recep Bedir |
|
| Annals of Diagnostic Pathology. 2021; 54: 151792 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer |
|
|
| Markus Eckstein, Charlotte Kimmel, Johannes Bruendl, Florian Weber, Stefan Denzinger, Michael Gierth, Maximilian Burger, Arndt Hartmann, Wolfgang Otto, Johannes Breyer |
|
| Scientific Reports. 2021; 11(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The histopathological and molecular features of breast carcinoma with tumour budding—a systematic review and meta-analysis |
|
|
| Angus J. Lloyd, Éanna J. Ryan, Michael R. Boland, Sami Abd Elwahab, Carmel Malone, Karl J. Sweeney, Kevin M. Barry, Raymond McLaughlin, Michael J. Kerin, Aoife J. Lowery |
|
| Breast Cancer Research and Treatment. 2020; 183(3): 503 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Markers of Cancer Cell Invasion: Are They Good Enough? |
|
|
| Tatiana S. Gerashchenko,Nikita M. Novikov,Nadezhda V. Krakhmal,Sofia Y. Zolotaryova,Marina V. Zavyalova,Nadezhda V. Cherdyntseva,Evgeny V. Denisov,Vladimir M. Perelmuter |
|
| Journal of Clinical Medicine. 2019; 8(8): 1092 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
